John B. Cheng

2.4k citations
59 papers · 2.0k indexed · h-index 23
Topics
Asthma and respiratory diseases (22 papers)Receptor Mechanisms and Signaling (14 papers)Phosphodiesterase function and regulation (14 papers)

In The Last Decade

John B. Cheng

58 papers receiving 1.8k citations

Peers

John B. Cheng
Comparison fields: 5 of 96
  • Molecular Biology 1.1k
  • Physiology 506
  • Pharmacology 413
  • Immunology 334
  • Organic Chemistry 242
Replace Yasushi Fujitani with:
Yasushi Fujitani Japan
Yves Boie Canada
J A Lindgren Sweden
Ruth R. Osborn United States
Lawrence de Garavilla United States
Johan Raud Sweden
El‐Bdaoui Haddad United Kingdom
Nancy Lewis Baenziger United States
Kimihiko Sano Japan
Fabien Schmidlin France
John B. Cheng relative to Yasushi Fujitani Japan Yasushi Fujitani's profile →
Citations per field
00.5×4.8×
Yasushi Fujitani · 1×
Citations per year

Countries citing papers authored by John B. Cheng

Since Specialization
Citations

This map shows the geographic impact of John B. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John B. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John B. Cheng more than expected).

Fields of papers citing papers by John B. Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John B. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John B. Cheng. The network helps show where John B. Cheng may publish in the future.

Co-authorship network of co-authors of John B. Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of John B. Cheng. A scholar is included among the top collaborators of John B. Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John B. Cheng. John B. Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 11
2 4
3 5
4 13
5 6
6 287
7 9
8 191
9 13
10 22
11 188
12 49
13 43
14 48
15 21
16 7
17 6
18 4
19 3
20 2

About John B. Cheng

John B. Cheng is a scholar working on Physiology, Pharmacology and Toxicology, having authored 59 papers that have together received 2.0k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (22 papers), Receptor Mechanisms and Signaling (14 papers) and Phosphodiesterase function and regulation (14 papers). The work is most often cited by research in Immunology and Allergy (154 citations), Pharmacology (413 citations) and Physiology (506 citations). John B. Cheng has collaborated with scholars based in United States, Japan and Netherlands. Frequent co-authors include Douglas A. Fisher, James F. Smith, Robert G. Townley, J. W. Watson, Shoji Shibata, Alan Goldfien, James M. Roberts, Victoria L. Cohan, Susan Tofte and Jon M. Hanifin. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026